Navigation Links
Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement
Date:8/10/2009

ROCHESTER, N.Y., Aug. 10 /PRNewswire/ -- Your sleeping problems might be caused by stress, depression, diet, or a disease such as Fibromyalgia (FM), and Chronic Fatigue Syndrome (CFS). But it can also be a result of a virus hiding in your body.

Recent studies show that chronic infection with viruses can cause sleep disorders. A recent scientific review written by Professor Mark Opp from the University of Michigan Medical School states that "Data reviewed demonstrate the extent to which sleep is altered during the course of (an) infection." In one of these studies, a team of scientists headed by Professor Jose G. Montoya from the University of Stanford School of Medicine showed that many people who suffer from a sleep disorder can benefit from an antiviral treatment. In this study a group of patients who had a high concentration of chronic viruses in their body and were suffering from sleep disturbances, were treated with the antiviral drug valganciclovir. The drug was highly successful. It resolved the sleep problems in 75% of the patients!

Gene-Eden(R): antiviral supplement for better sleep

The development of Gene-Eden was inspired by Dr. Hanan Polansky's discovery of the role of chronic viruses in chronic disease. To develop an effective supplement, the scientists at polyDNA scanned the scientific literature, read and analyzed thousands of papers, and identified natural ingredients which are effective against chronic viruses. The result is Gene-Eden(R), an antiviral supplement that targets viruses during their chronic infection phase, and as expected, is effective in getting better sleep.

For more information on Gene-Eden(R), and a chance for better sleep, visit http://www.gene-eden.com/sleep.htm

What about the sleeping pills like Ambien and supplements like melatonin?

According to the Consumer Reports website: "Most sleep drugs are supposed to be taken for no longer than two weeks or so, and continued use could lead to serious side effects or dependency; 'rebound' insomnia, in which sleeplessness returns and might actually worsen; memory lapses; and hallucinations."

What is the reason for these side effects? Sleeping pills like Ambien and supplements like melatonin change the chemistry in the brain and create an artificial chemistry more conducive to sleep. However, this artificial chemistry also produces the serious side effects, and because of the adoptive nature of the brain, the dreaded dependency.

Unlike these sleeping pills and supplements, Gene-Eden targets a common cause of the sleeping problems, chronic viruses in the body. Gene-Eden does not create an artificial chemistry, but recovers the more natural, healthy state characteristic of a system with little or no chronic viruses, a system that experiences uninterrupted, refreshing sleep.

For more information on Gene-Eden(R), and a chance for better sleep, visit http://www.gene-eden.com/sleep.htm

About:

The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a non-profit center with a mission to advance the research on the biology of chronic disease, and to accelerate the discovery of a cure for these diseases.

    Contact:

    Tal Davidson
    Phone: 585-200-5546
    Email: tdavidson@cbcd.net

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE The Center for the Biology of Chronic Disease
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Limb-sparing surgery may not provide better quality of life than amputation for bone cancer patients
2. Not-For-Profit Nursing Homes Fare Better in Studies
3. Tabyat Partners, LLC. Launches iluvmydoc.com™, to Better Connect Patients with Doctors
4. Freshly crushed garlic better for the heart than processed
5. For Some Kidney Patients, Home Dialysis Is Better
6. Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month
7. Charlotte Attorney Calls on North Carolina Senate to Pass "Comparative Negligence" Bill in Order to Better Protect Injury Victims in State
8. NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
9. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
10. Can pen and paper help make electronic medical records better?
11. Look Good...Feel Better and OPI Celebrate 20 Years of Helping Women Cope With Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... LOUIS (PRWEB) , ... April 26, 2017 , ... ... designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping beverage ... economic alternative to dairy proteins, providing direct cost savings as well as more ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... proud to announce that it has received 510(k) clearance from the U.S. Food ... and the MyoCycle Pro. , Both devices are stationary cycling systems that use ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , the ... This new addition to the Mirroring360 product family combines device screen mirroring with ... Pro enables educators, business professionals and individuals to stream or mirror app screens, ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... California, committed to raising awareness for Duchenne muscular dystrophy, and funding for ... CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President ... are preparing for how his administration could impact the employee benefits industry. James ... changes are most likely to make it through Congress. His discussion will focus ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: